Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Medicortex International

1.30 SEK+5.28 %3.9, 16.36
Less than 1K followers

MEDFIN B

NGM Growth Market

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor views
Compare
+5.28 %
-8.80 %
-52.04 %
-44.89 %
-60.28 %
-67.63 %
-96.31 %
-98.94 %
-99.20 %

Medicortex International is a medical technology company that develops diagnostic solutions for traumatic brain injuries, with a focus on biomarker-based tests. The company conducts research and development with the goal of enabling rapid and accessible diagnostics and works long-term with the development of treatment solutions. The business has an international focus.

Read more
Market cap
30.22M SEK
Turnover
8.37K SEK
Revenue
4.98M
EBIT %
-117.87 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
All
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Regulatory press release01.09.2026, 13.48

Medicortex International AB (publ) enters into agreements ahead of planned directed set-off share issues totalling approximately SEK 9.9 million

Medicortex International
Regulatory press release31.08.2026, 16.37

Medicortex International AB (publ) publishes interim report for the period April–June 2026

Medicortex International
Regulatory press release28.08.2026, 16.58

Medicortex International AB (publ): Interim Report for the Second Quarter of 2026 to be Published on 31 August 2026

Medicortex International

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release20.08.2026, 13.10

A New Chapter for Medicortex International – From Scientific Innovation to Commercial Execution

Medicortex International
Press release11.08.2026, 09.00

Shareholder Update – August 2026

Medicortex International
Regulatory press release06.07.2026, 09.05

CEO Letter: Leading the Future of Brain Injury Diagnostics

Medicortex International
Third party research11.09.2023, 14.43

Nosium: Nya målsättningar att sikta mot - Analyst Group

Under de senaste månaderna har NOSIUM kommunicerat flera nyheter och det är tydligt att aktiviteten kring bolaget är fortsatt hög. Vid utgången av årets andra kvartal bestod NOSIUM:s portfölj av totalt 14 innehav och med hänsyn till senast aktuell information...

Medicortex International